Nantahala Capital Management, LLC Eledon Pharmaceuticals, Inc. Transaction History
Nantahala Capital Management, LLC
- $1.5 Billion
- Q2 2024
A detailed history of Nantahala Capital Management, LLC transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 600,000 shares of ELDN stock, worth $3.18 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
600,000
Previous 600,000
-0.0%
Holding current value
$3.18 Million
Previous $1.58 Million
-0.0%
% of portfolio
0.11%
Previous 0.11%
Shares
1 transactions
Others Institutions Holding ELDN
# of Institutions
34Shares Held
18.3MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA6.29MShares$33.4 Million0.51% of portfolio
-
Armistice Capital, LLC New York, NY2.34MShares$12.4 Million0.08% of portfolio
-
Zimmer Partners, LP New York, NY2.11MShares$11.2 Million0.11% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.5MShares$7.95 Million0.03% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.3MShares$6.87 Million0.5% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $72.9M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...